Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palbociclib plus letrozole vs letrozole alone in Thai hormone receptor-positive advanced breast cancer
TCTR20180920002Phase 4Active, not recruiting
- Sponsor
- Thai Society of Clinical Oncology
- Start
- Sep 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of palbociclib, letrozole in breast cancer, sponsored by Thai Society of Clinical Oncology. Started Sep 2018; status: active, not recruiting.
02
Drugs
palbociclibletrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on TCTR20180920002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180920002.